At Golden Helix, customer support is our number one priority. This commitment extends beyond technical assistance—it includes the health, safety, and overall well-being of our entire community. During this time of global uncertainty, we want to first acknowledge the incredible dedication of healthcare professionals and frontline workers around the world. Their efforts to combat the COVID-19 outbreak are nothing short of heroic.
We also recognize that many of our customers are experiencing significant disruptions in their workplaces. With universities moving to remote instruction, research institutions reducing on-site access, and organizations implementing work-from-home policies, we understand that many users may no longer have access to their primary devices with Golden Helix software installed.
In response, we’ve launched the COVID-19 Remote Access Assistance Program, designed to ensure continuity of research and analysis. This program allows impacted users to request temporary license installations on alternate devices to enable remote access and uninterrupted workflows during this period of transition.
We remain dedicated to being a reliable and supportive partner, no matter where you are working from. Our goal is to make sure you can continue your critical research without added stress or delay. Whether you’re analyzing genetic data, supporting clinical diagnostics, or continuing academic research, we are here to help you adapt.
If you are in need of an additional temporary license, please contact your Account Manager directly or email our team at [email protected] for further assistance.
Health and safety are a shared responsibility. By working together and supporting each other, we can help slow the spread of COVID-19 and continue pushing forward.
Dr. Andreas Scherer is CEO of Golden Helix. The company has been delivering industry leading bioinformatics solutions for the advancement of life science research and translational medicine for over a decade. Its innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from next-generation sequencing. With its solutions, hundreds of the world’s hospitals and testing labs are able to harness the full potential of genomics to identify the cause of disease, develop genomic diagnostics, and advance the quest for personalized medicine. Golden Helix products and services have been cited in thousands of peer-reviewed publications. Golden Helix is also on the Inc 5000 list of the fastest-growing private companies in the US.
He is also Managing Partner of Salto Partners, Inc, a management consulting firm headquartered in Nevada. He has extensive experience successfully managing growth as well as orchestrating complex turnaround situations. His company, Salto Partners, advises on business strategy, financing, sales, and operations. Clients are operating in the high-tech and life sciences space.
Dr. Scherer holds a Ph.D. in computer science from the University of Hagen, Germany, and a Master of Computer Science from the University of Dortmund, Germany. He is author and co- author of over 20 international publications and has written books on project management, the Internet, and artificial intelligence. His latest book, “Be Fast Or Be Gone”, is a prizewinner in the 2012 Eric Hoffer Book Awards competition, and has been named a finalist in the 2012 Next Generation Indie Book Awards!
